Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» B.1.1.7 variant
B.1.1.7 variant
J&J single shot sees 66% efficacy in moderate COVID-19, 85% in severe cases; shares fall
Fierce Biotech
Fri, 01/29/21 - 10:14 am
JNJ
vaccines
COVID-19
B.1.1.7 variant
B.1.351 variant
Pfizer and Moderna haven't proven their COVID-19 vaccines shield against new variants: analysts
Fierce Pharma
Thu, 01/28/21 - 11:00 am
vaccines
COVID-19
Pfizer
Moderna Therapeutics
BioNTech
B.1.1.7 variant
B.1.351 variant
Early studies suggest Pfizer/BioNTech vaccine is effective against South African strain
Biopharma Reporter
Thu, 01/28/21 - 10:43 am
Pfizer
BioNTech
COVID-19
vaccines
B.1.1.7 variant
B.1.351 variant
Pfizer working on booster shot to protect against COVID-19 variants
Reuters
Tue, 01/26/21 - 11:48 pm
Pfizer
BioNTech
vaccines
COVID-19
B.1.1.7 variant
B.1.351 variant
Moderna says its Covid-19 vaccine is less effective against one coronavirus variant
Stat
Mon, 01/25/21 - 10:59 am
Moderna Therapeutics
South Africa
vaccines
COVID-19
B.1.351 variant
B.1.1.7 variant
Gilead says Veklury should work against COVID-19 variants
Pharmaforum
Fri, 01/22/21 - 10:42 am
Gilead Sciences
Veklury
remdesivir
B.1.1.7 variant
Pfizer-BioNTech Covid-19 vaccine works just as well against variant first detected in U.K., study indicates
Stat
Wed, 01/20/21 - 10:56 am
Pfizer
BioNTech
COVID-19
vaccines
UK
B.1.1.7 variant
CDC: New Coronavirus Variant Could Become Dominant, Lead To More Covid-19, Deaths
Forbes
Tue, 01/19/21 - 10:41 am
CDC
COVID-19
coronavirus
pandemic
B.1.1.7 variant
FDA warns about COVID-19 molecular test false negatives as virus mutates
Mass Device
Mon, 01/11/21 - 09:58 am
diagnostics
COVID-19
B.1.1.7 variant
FDA